These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14066258)

  • 21. [Diminution of postoperative thromboembolic complications by prophylaxis with panthesine-hydergin (PH 203)].
    MOSER H
    Wien Klin Wochenschr; 1959 Aug; 71():635-7. PubMed ID: 14424531
    [No Abstract]   [Full Text] [Related]  

  • 22. [Additional observations on the treatment of myocardial infarct in old age with Panthesin and Hydergin (PH 203)].
    THEINL K
    Wien Klin Wochenschr; 1961 Feb; 73():143-5. PubMed ID: 13776197
    [No Abstract]   [Full Text] [Related]  

  • 23. [TREATMENT OF APOPLEXY WITH PANTHESIN-HYDERGIN].
    MAYER-BIRKHOF KR
    Munch Med Wochenschr; 1964 Aug; 106():1464-5. PubMed ID: 14242476
    [No Abstract]   [Full Text] [Related]  

  • 24. [PARESIS OF THE INTESTINE AND LOWER EXTREMITIES DURING PREGNANCY AND THE PUERPERIUM: CURATIVE EFFECT OF POTASSIUM. ATTEMPTED INTREPRETATION].
    MULLER P; ESCHBACH J; DELLENBACH P
    Bull Fed Soc Gynecol Obstet Lang Fr; 1964; 16():82-4. PubMed ID: 14156805
    [No Abstract]   [Full Text] [Related]  

  • 25. [USE OF COHN'S FRACTION I IN GYNECOLOGY AND OBSTETRICS].
    HRUBISKOVA K; HRUBISKO M
    Cesk Gynekol; 1964 Feb; 29():119-24. PubMed ID: 14142644
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparative plethysmographic study of the venoconstrictor effect of dihydroergotamine and dihydroergotoxine on the deep veins of the calf in healthy subjects and patients suffering from varicosis.
    Barthel W; Grossmann K
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):458-64. PubMed ID: 7141753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [ARTERITIS OBLITERANS OF THE LOWER EXTREMITIES ESPECIALLY FROM THE CLINICAL VIEWPOINT].
    EIRENES S; GIOTES X
    Hell Cheirourgike; 1963; 10():756-79. PubMed ID: 14096712
    [No Abstract]   [Full Text] [Related]  

  • 28. [DETERMINATION OF NON-HYDROGENATED AND HYDROGENATED ERGOT ALKALOIDS].
    GAWRYCH Z; WILCZYNSKA I
    Acta Pol Pharm; 1965; 22():1-12. PubMed ID: 14311546
    [No Abstract]   [Full Text] [Related]  

  • 29. [POSTPARTUM VARICOSE PHLEBITIS. CLINICAL AND THERAPEUTIC ASPECTS].
    HARTEMANN J; STREIFF F; DELLESTABLE P; DESCHAMPS J
    Concours Med; 1965 Apr; 87():2347-57. PubMed ID: 14338705
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of PH 203 (panthesine hydergine) in thrombo-embolic diseases in obstetrics and gynaecology.
    GANS B; ECKERLING B; SAX B
    S Afr Med J; 1959 Aug; 33():707-9. PubMed ID: 13826317
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparison of pheylbutazone and P.H. 203 in the treatment of superficial puerperal phlebitis].
    LANCET M
    Harefuah; 1961 May; 60():289-91. PubMed ID: 13758620
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of thromboembolism with PH203].
    RAPPERT E
    Klin Med Osterr Z Wiss Prakt Med; 1959 Feb; 14(2):71-86. PubMed ID: 13655543
    [No Abstract]   [Full Text] [Related]  

  • 33. [Efficacy of treatment with Ph 203 in the prevention of postoperative thromboemboli; preliminary results in 50 cases after operation for diskal hernia].
    BARONTINI F
    Minerva Med; 1956 Sep; 47(72):597-9. PubMed ID: 13387152
    [No Abstract]   [Full Text] [Related]  

  • 34. [Some problems in the potentiation of i. v. anesthesia in gynecology].
    NEMES J
    Magy Noorv Lapja; 1962 Jan; 25():45-52. PubMed ID: 14478976
    [No Abstract]   [Full Text] [Related]  

  • 35. [MUSCULOTROPHIC ACTION OF THE NATURAL AND HYDROGENATED ERGOT ALKALOIDS].
    BRUGGER A; ESPLUGUES J
    Med Esp; 1964 Feb; 51():94-102. PubMed ID: 14138514
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hydrogenated ergot alkaloids (hydergin) in therapy of peripheral circulatory disorders].
    EHREN H
    Dtsch Med Wochenschr; 1951 Oct; 76(43):1334-7. PubMed ID: 14896779
    [No Abstract]   [Full Text] [Related]  

  • 37. Hydrogenated ergot alkaloids in treatment of intermittent claudication.
    LUKE JC; MARIEN BN
    Can Med Assoc J; 1953 Mar; 68(3):221-4. PubMed ID: 13032858
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevention of labor and puerperal hemorrhage by the intravenous administration of ergot alkaloids].
    LITVINOVA IuP
    Pediatr Akus Ginekol; 1962; 1():48-9. PubMed ID: 14465927
    [No Abstract]   [Full Text] [Related]  

  • 39. Pregnancy-induced changes in lower extremity superficial veins: an ultrasound scan study.
    Boivin P; Cornu-Thenard A; Charpak Y
    J Vasc Surg; 2000 Sep; 32(3):570-4. PubMed ID: 10957666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [THE EFFECTS OF HYDROGENATED ERGOT ALKALOIDS ON THYROID FUNCTION].
    REVICZKY AL; SZANTO L; GRYNAEUS T
    Arzneimittelforschung; 1964 Nov; 14():1230-3. PubMed ID: 14317938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.